J.P. Morgan and Wolfe Research analysts cited uncertainty and pricing concerns in Medicare Advantage and cost pressures in the commercial market when downgrading major U.S. payers.
J.P. Morgan and Wolfe Research analysts cited uncertainty and pricing concerns in Medicare Advantage and cost pressures in the commercial market when downgrading major U.S. payers.